Elective Surgery Clinical Trial
— PROPOREVOfficial title:
Efficacy of an Intravenous Dose of Propofol Versus Placebo in the Prevention of Coughing During Emergence of General Anesthesia Under Desflurane
Verified date | January 2018 |
Source | Centre hospitalier de l'Université de Montréal (CHUM) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Emergence of general anesthesia is a critical period, in the same way as the induction of
anesthesia, during which several adverse events may occur. Extubation may even be more
difficult than the intubation, with a higher respiratory complications rate. Among these,
cough is common and expected. It can be associated with significant complications including
hypertension, tachycardia, increased intracranial pressure, bleeding at the surgical site or
even wound dehiscence.
The incidence of coughing during emergence of general anesthesia varies depending on the type
of airway instrumentation, the population under study, agents used for the maintenance of the
anesthesia and techniques used to prevent coughing. In the literature, the incidence of
coughing during emergence of general anesthesia under endotracheal intubation varies from 38
to 96%. In our center, the incidence of coughing during emergence of general anesthesia under
desflurane and endotracheal intubation is 30 % according to a local preliminary study.
Propofol is well-known to inhibit airway reflexes. Total intravenous anesthesia (TIVA) is
associated with a lower incidence of coughing compared to inhalated anesthesia. The efficacy
of propofol at a subhypnotic dose to reduce coughing during emergence has recently been
demonstrated in patients undergoing nasal surgery under sevoflurane. However, the most
effective antitussive dose remains unknown and its efficacy during anesthesia under
desflurane has not yet been demonstrated.
Propofol is rapidly available, simple to administer and has an interesting pharmacological
profile, among others due to its short half-life.
The aim of this study is to evaluate if an intravenous bolus of 0.5 mg/kg of propofol is more
effective than placebo administration to decrease the incidence of coughing during emergence
of general anesthesia under desflurane (PROPOREV). Propofol could also reduce the incidence
of postoperative nausea and vomiting (PONV).
Status | Completed |
Enrollment | 154 |
Est. completion date | December 2017 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Adult patients aged between 18 to 80 years undergoing elective surgery under general anesthesia with an orotracheal intubation; - Patients of American Society of Anesthesiologists (ASA) I to III inclusively at the preoperative evaluation - Patients affiliated to a medical insurance system. Exclusion Criteria: 1. Ear, nose and throat (ENT) surgery, thoracic and neurological surgery ; 2. Participation refusal; 3. Patient allergic to or presenting a contraindication to propofol; 4. Patient with a tracheostomy; 5. Chronic coughing, i.e. daily cough for 8 weeks or more; 6. Asthma / severe or exacerbated chronic obstructive pulmonary disease (COPD); 7. Recent respiratory tracts infection (< 4 weeks); 8. Hemostasis disorders; 9. Patient known for a non-secure cerebral aneurysm; 10. Patient known for a difficult intubation (grade 3 or 4); 11. Patient suffering from mental, neurological, or severe cardiovascular disease; 12. Pregnant or breastfeeding women; 13. Patients with deafness and/or unable to have conversations in a normal voice; 14. Patient with language barrier (not speaking French, nor English); 15. Patient suffering from dementia or patient under guardianship. |
Country | Name | City | State |
---|---|---|---|
Canada | CHUM | Montreal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Centre hospitalier de l'Université de Montréal (CHUM) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of coughing (between discontinuation of desflurane and minimum alveolar concentration (MAC) of 0.15 of desflurane) | Incidence of coughing during emergence of general anesthesia (between discontinuation of desflurane and MAC of 0.15 of desflurane) and its severity based on a 4-grade scale | one day, perioperative period | |
Secondary | Incidence of coughing (between discontinuation of desflurane, MAC of 0.1 and 0.2 of desflurane, at extubation, as well as 5 and 10 min after extubation) | Incidence of coughing during emergence of general anesthesia (between MAC of 0.15 of desflurane and until 10 min after extubation) and its severity based on a 4-grade scale | one day, perioperative period | |
Secondary | Extubation time | Interval between discontinuation of desflurane and extubation | one day, perioperative period | |
Secondary | Sedation of the patient | Sedation of the patient two, five and ten minutes following extubation, then at 15 minutes interval in the recovery room, based on the Observer's Assessment of Alertness/Sedation Scale (OAA/A), until 30 minutes after the admission in the recovery room | one day, perioperative period | |
Secondary | Incidence of hypoventilation | incidence of hypoventilation (breathing rate < 8/min) | one day, perioperative period | |
Secondary | Incidence of hypoxic episode | incidence of hypoxic episode (oxygen saturation < 90%) | one day, perioperative period | |
Secondary | Blood pressure | Measurement of blood pressure before the induction and during emergence (every 5 min) in order to calculate incidence of fluctuation of non invasive blood pressure and heart rate of more than 20% between the values before induction of anesthesia until 10 min after extubation | one day, perioperative period | |
Secondary | Heart rate | Measurement of heart rate before the induction and during emergence (every 5 min) in order to calculate incidence of fluctuation of non invasive blood pressure and heart rate of more than 20% between the values before induction of anesthesia until 10 min after extubation | one day, perioperative period | |
Secondary | Agitation of the patient during emergence | Note the possible agitation of the patient during emergence | one day, perioperative period | |
Secondary | Complications | Describe potential complications secondary to the bolus of the substance under study at the emergence | one day, perioperative period | |
Secondary | Cumulative incidence of nausea/vomiting | Calculate cumulative incidence of nausea/vomiting between extubation and 30 minutes after the admission in the recovery room | one day, perioperative period | |
Secondary | Swallowing pain scores | Evaluate swallowing pain scores evaluated using a verbal simple numeric scale (0 = no pain et 10 = worst pain imaginable) 30 min after extubation | one day, perioperative period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04361799 -
Perioperative Closed-loop Glucose Control
|
N/A | |
Completed |
NCT01193972 -
Decision Aid Development for Smokers
|
Phase 1 | |
Completed |
NCT00795392 -
Preoperative Psychological Evaluation as Predictor of Outcomes
|
N/A | |
Completed |
NCT00966186 -
The Rotational Insertion Technique for ProSeal Laryngeal Mask Airway
|
N/A | |
Completed |
NCT01856998 -
Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective Surgery
|
Phase 3 | |
Not yet recruiting |
NCT06344325 -
ED90 of Fospropofol Disodium in Induction and Maintenance of Anesthesia
|
Phase 4 | |
Completed |
NCT03857750 -
Neuromuscular Blocking Agents in the Elderly
|
||
Completed |
NCT00875134 -
Testing of the Apnea Prevention Device
|
Phase 1/Phase 2 | |
Completed |
NCT00290108 -
The Influence of Injection Rate on EEG Propofol Peak Effect as Measured by Bispectral Index
|
N/A | |
Completed |
NCT04020887 -
Telemedicine Control Tower for the Post-Anesthesia Care Unit
|
N/A | |
Not yet recruiting |
NCT06039306 -
Perioperative Immunonutrition Under Enhanced Recovery After Surgery
|
N/A | |
Completed |
NCT00948597 -
Development of PK/PD Model for Individualized Propofol Dosing
|
N/A | |
Completed |
NCT00776880 -
Does American Society of Anesthesiologists (ASA) Physical Status Scale Enough in Patients Assessment
|
N/A | |
Completed |
NCT04089592 -
Comparison Of Dexmedetomidine and Fentanyl In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy.
|
N/A | |
Not yet recruiting |
NCT03593252 -
Bowel Preparation in Elective Pediatric Colorectal Surgery
|
N/A | |
Not yet recruiting |
NCT04225702 -
Effect Of Aspirin Preoperative on Postoperative Cognitive Dysfunction In Elderly Patients Undergoing Knee Arthroplasty
|
||
Recruiting |
NCT05647252 -
General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery
|
Phase 3 | |
Completed |
NCT00205244 -
Preoperative Preparation for Children
|
N/A | |
Completed |
NCT05392452 -
Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)
|
N/A | |
Completed |
NCT03455413 -
Quality of Perioperative Invasive Ventilation in PICU
|